Skip to Main Content

Author Details

David T Miyamoto
Massachusetts General Hospital
2000
55
30
PMIDPaper TitleJournal TitlePublished Year
36940384A pair of deep learning auto-contouring models for prostate cancer patients injected with a radio-transparent versus radiopaque hydrogel spacer.Med Phys2023
37992168ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer.Sci Adv2023
37870965Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer.Clin Cancer Res2023
37187202Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.Lancet Oncol2023
37327786DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs.Cell2023
36424075Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers.Urol Clin North Am2023
34619374Characterization of an Iodinated Rectal Spacer for Prostate Photon and Proton Radiation Therapy.Pract Radiat Oncol2022
35045985Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition.Cancer Res2022
33422353Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.Eur Urol2021
34041029Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies.Front Oncol2021
33257220Bladder preservation: Translating discovery for clinical impact in urothelial cancer.Urol Oncol2021
32205136Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences.Eur Urol Oncol2020
31814454Noncanonical Wnt as a prognostic marker in prostate cancer: "you can't always get what you Wnt".Expert Rev Mol Diagn2020
32900554PIK Carefully, AKT Accordingly: Towards Precision Medicine in Prostate Cancer.Eur Urol2020
30819896COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis.Proc Natl Acad Sci U S A2019
30712971Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.Eur Urol2019
30952638Molecular Characterization of Neuroendocrine-like Bladder Cancer.Clin Cancer Res2019
30910345Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol 2019;76:69-70: Towards Biomarker-Informed Management of Muscle-Invasive Bladder Cancer.Eur Urol2019
29326053Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration.Adv Drug Deliv Rev2018
30104333A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer.Cancer Discov2018
30507435Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer.Lancet Oncol2018
29453278Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy.Proc Natl Acad Sci U S A2018
29426693Clinical needs assessment for sexual health among cancer patients receiving pelvic radiation: Implications for development of a radiation oncology sexual health clinic.Pract Radiat Oncol2018
29301747An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer.Cancer Discov2018
27440270Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer.Clin Cancer Res2017
28181495Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination.Nat Commun2017
28096363An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.Proc Natl Acad Sci U S A2017
29170510Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells.Nat Commun2017
26999591Deformability-based cell selection with downstream immunofluorescence analysis.Integr Biol (Camb)2016
28389596Single-Cell Analysis of Circulating Tumor Cells as a Window into Tumor Heterogeneity.Cold Spring Harb Symp Quant Biol2016
27926867Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal Transition.Cell Rep2016
27924634The promise of circulating tumor cells for precision cancer therapy.Biomark Med2016
27771279Cell-free and circulating tumor cell-based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?Urol Oncol2016
27321150Outcomes with image-based interstitial brachytherapy for vaginal cancer.Radiother Oncol2016
25984697A microfluidic device for label-free, physical capture of circulating tumor cell clusters.Nat Methods2015
26383955RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance.Science2015
26679988Deformability of Tumor Cells versus Blood Cells.Sci Rep2015
24726149Weight gain on androgen deprivation therapy: which patients are at highest risk?Urology2014
25242334Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells.Cell Rep2014
25171411Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.Cell2014
24821215Circulating tumour cells-monitoring treatment response in prostate cancer.Nat Rev Clin Oncol2014
23552373Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells.Sci Transl Med2013
23762284Concurrent chemoradiation for vaginal cancer.PLoS One2013
23553848A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases.Clin Cancer Res2013
23093251Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer.Cancer Discov2012
21134652Molecular predictors of local tumor control in early-stage breast cancer.Semin Radiat Oncol2011
19800182Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older.Int J Radiat Oncol Biol Phys2010
20930119Isolation of circulating tumor cells using a microvortex-generating herringbone-chip.Proc Natl Acad Sci U S A2010
20424012Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer.Sci Transl Med2010
19788436Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older.Dis Esophagus2010
  • 1 - 50 of 55

Recommended Authors

Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 2
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 8
Lisanne F van Dessel
Erasmus MC Cancer Institute
Career Start Year 2015
Number of shared co-authors 2
Stephanie A Wankowicz
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 5
Zafeiris Zafeiriou
Theageneion Anticancer Hospital
Career Start Year 2013
Number of shared co-authors 4
Ryan Dittamore
Decipher Biosciences Inc.
Career Start Year 2013
Number of shared co-authors 7
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 8
Himisha Beltran
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 13
Susana Miranda
The Institute of Cancer Research
Career Start Year 2008
Number of shared co-authors 6
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 8
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 1
Bishoy M Faltas
Sandra and Edward Meyer Cancer Center
Career Start Year 2007
Number of shared co-authors 1
Arun A Azad
Peter MacCallum Cancer Centre
Career Start Year 2007
Number of shared co-authors 6
Alan H Bryce
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 2
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 2
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 9
Niven Mehra
Radboud university medical center
Career Start Year 2004
Number of shared co-authors 8
Adam Sharp
The Institute for Cancer Research
Career Start Year 2003
Number of shared co-authors 7
Adam Foye
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 5
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2001
Number of shared co-authors 10
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 9
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 5
Evan Y Yu
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 10
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 8
Phuoc T Tran
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 12
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 5
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 4
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 15
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 11
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 5

Collaborators

Mehmet Toner
Co-authored papers 20
Lecia V Sequist
Massachusetts General Hospital Cancer Center, Harvard Medical School
Co-authored papers 12
Aditya Bardia
Massachusetts General Hospital Cancer Center
Co-authored papers 4
Yang Liu
Veracyte inc.
Co-authored papers 3
Elai Davicioni
Veracyte Inc.
Co-authored papers 3
Wilhelm Haas
Co-authored papers 3
Andrzej Niemierko
Massachusetts General Hospital
Co-authored papers 2
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 2
Jonathan L Wright
University of Washington Medical Center
Co-authored papers 2
Michiel S van der Heijden
the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
Co-authored papers 2
Raymond T Chung
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 1
Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Co-authored papers 1
David N Louis
Co-authored papers 1
Nabeel Bardeesy
Massachusetts General Hospital
Co-authored papers 1
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Co-authored papers 1
Toni K Choueiri
Dana-Farber Cancer Institute
Co-authored papers 1
Catharine M L West
University of Manchester
Co-authored papers 1
Adam G Sowalsky
National Cancer Institute
Co-authored papers 1
Robert G Bristow
University of Toronto
Co-authored papers 1
Anthony J Iafrate
Massachusetts General Hospital
Co-authored papers 1
Alexander W Wyatt
University of British Columbia
Co-authored papers 1
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
David A Weitz
Co-authored papers 1
Li-Huei Tsai
The Picower Institute for Learning and Memory, Massachusetts Institute of Technology
Co-authored papers 1
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Co-authored papers 1
Ladan Fazli
University of British Columbia
Co-authored papers 1
Alejandro Athie
Vall d'Hebron Institute of Oncology (VHIO)
Co-authored papers 1
Ronald G Tompkins
Massachusetts General Hospital
Co-authored papers 1
Michael S Lawrence
Co-authored papers 1
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 1
Release 1.2